Background: Although general practitioners (GPs) are frequently the first healthcare professionals whom asthma patients refer to for their symptoms, few studies have explored the extent of adherence to guidelines for asthma management based on data provided directly by GPs. Aims of the present study were to assess drug prescriptions for asthma by GPs and to evaluate prescriptive adherence to GINA guidelines (GL) and its relationship with disease control in real life. Methods: 995 asthmatic patients (45% males, mean age 43.3 ± 17.7 yrs) were enrolled by 107 Italian GPs distributed throughout the country. Data on diagnosis, disease severity, prescribed anti-asthmatic drugs and control were collected through questionnaires filled out by GPs taking into consideration the 2009 GINA Guidelines. Data on drug use and chronic sinusitis, nasal polyposis, chronic bronchitis, emphysema were reported by patients through a self-administered questionnaire. Results: The large majority of patients were classified by GPs as having intermittent (48.4%) or mild persistent asthma (25.3%); 61% had co-morbid allergic rhinitis (AR). The prevalent therapeutic regimen used by patients was a combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) (54.1%), even in the intermittent/mild persistent group. ICS as mono-therapy or in combination with other drugs but LABA, was the second most frequently adopted treatment (14.4%). In general, the GPs adherence to GL treatment indications was 28.8%, with a significant association with a good asthma control (OR 1.85, 95% CI 1.18–2.92). On the other hand, comorbidity (OR 0.52, 95% CI 0.32–0.84), moderate (0.44, 0.28–0.69) and severe (0.06, 0.02–0.20) persistent asthma showed significant negative effects on asthma control. Conclusions: Our results show that over-treatment of intermittent/mild persistent asthma is frequent in the GPs setting while therapeutic regimens are more appropriately applied for moderate/severe asthma. In general, we found low adherence to GINA GL treatment recommendations even if its relevance in asthma control was confirmed.

Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice

Paggiaro, Pierluigi;Carrozzi, Laura;Pistelli, Francesco;
2019-01-01

Abstract

Background: Although general practitioners (GPs) are frequently the first healthcare professionals whom asthma patients refer to for their symptoms, few studies have explored the extent of adherence to guidelines for asthma management based on data provided directly by GPs. Aims of the present study were to assess drug prescriptions for asthma by GPs and to evaluate prescriptive adherence to GINA guidelines (GL) and its relationship with disease control in real life. Methods: 995 asthmatic patients (45% males, mean age 43.3 ± 17.7 yrs) were enrolled by 107 Italian GPs distributed throughout the country. Data on diagnosis, disease severity, prescribed anti-asthmatic drugs and control were collected through questionnaires filled out by GPs taking into consideration the 2009 GINA Guidelines. Data on drug use and chronic sinusitis, nasal polyposis, chronic bronchitis, emphysema were reported by patients through a self-administered questionnaire. Results: The large majority of patients were classified by GPs as having intermittent (48.4%) or mild persistent asthma (25.3%); 61% had co-morbid allergic rhinitis (AR). The prevalent therapeutic regimen used by patients was a combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) (54.1%), even in the intermittent/mild persistent group. ICS as mono-therapy or in combination with other drugs but LABA, was the second most frequently adopted treatment (14.4%). In general, the GPs adherence to GL treatment indications was 28.8%, with a significant association with a good asthma control (OR 1.85, 95% CI 1.18–2.92). On the other hand, comorbidity (OR 0.52, 95% CI 0.32–0.84), moderate (0.44, 0.28–0.69) and severe (0.06, 0.02–0.20) persistent asthma showed significant negative effects on asthma control. Conclusions: Our results show that over-treatment of intermittent/mild persistent asthma is frequent in the GPs setting while therapeutic regimens are more appropriately applied for moderate/severe asthma. In general, we found low adherence to GINA GL treatment recommendations even if its relevance in asthma control was confirmed.
2019
Baldacci, Sandra; Simoni, Marzia; Maio, Sara; Angino, Anna; Martini, Franca; Sarno, Giuseppe; Cerrai, Sonia; Silvi, Patrizia; Pala, Anna Paola; Bresciani, Megon; Paggiaro, Pierluigi; Viegi, Giovanni; Di Pede, Francesco; Piegaia, Bona Barbara; Mangione, Maurizio; Bacci, Elena; Carrozzi, Laura; Dente, Federico; Pistelli, Francesco; Bancalari, Lorenza; Foschino, Maria Pia; Pelucchi, Andrea; Moscato, Gianna; Pierimarchi, Pasquale; Brunetto, Barbara; Iacovacci, Patrizia; Pini, Carlo; Tinghino, Raffaella; Forastiere, Francesco; Perucci, Carlo Alberto; Porta, Daniela; Ancona, Laura; Protasi, Sara; Lazazzera, Barbara; Ziroli, Valentina; D'Armini, Eleonora; Campanile, Sabella Festa; Ferri, Monica; Lorusso, Paola; Pistelli, Riccardo; Salotti, Rita; Santagati, Marco; Agea, Elisabetta; Casciari, Chiara; Murgia, Nicola; Spinozzi, Fabrizio; Bonifazi, Floriano; Antonicelli, Leonardo; Braschi, Maria Chiara; Conti, Valeria; Filippelli, Amelia; Corbi, Grazia Maria; Russomanno, Giusy; Braido, Fulvio; Canonica, Walter; Balbi, Francesco; Cerveri, Isa; Corsico, Angelo; Grosso, Amelia
File in questo prodotto:
File Dimensione Formato  
Baldacci (ARGA), Respir Med 2019.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 789.58 kB
Formato Adobe PDF
789.58 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/953827
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 21
social impact